CClinicalTrials.gg
Active, not recruitingNCT07203651Updated Oct 2, 2025

Comparison Between Diclofenac and Sterile Water Injection for Relief of Labour Associated Bachache

An interventional study of Sterile Water Injection and Diclofenac in Labour Analgesia, sponsored by Pakistan Institute of Medical Sciences. Active, not recruiting at 1 site in Pakistan. Open to female participants. Per ClinicalTrials.gov, last updated 2025-10-02.

Sponsored by Pakistan Institute of Medical Sciences · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Jan 2025, registered Jun 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Sex
Female
01

Study summary

Comparison of Intradermal sterile water injection with diclofenac for relief of labour associated bachache

02

Conditions studied

  • Labour Analgesia
03

In context

Lead sponsor

Pakistan Institute of Medical Sciences is the lead sponsor of 51 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Pregnant females in active stage of labour

Exclusion criteria

Exclusion Criteria:

  • females asking for epidural
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Investigator)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    group receiving intradermal sterile water injection

    Drug: Sterile Water Injection

  • Experimental
    Group receiving diclofenac injection

    Drug: Diclofenac

Interventions

  • DrugSterile Water Injection

    WE will compare effectiveness of intradermal sterile water injection with intramuscular diclofenal

  • DrugDiclofenac

    comparing effectiveness of diclofenac with intradermal sterile water injection

06

What researchers measure

Primary outcomes

  1. Pain relief

    relief of labour associated bachache using visual analogue pain scale. Scale is from 0 to 10 score. Score 0 means no pain and Score 10 keans worst possible pain. 1-2 Score: Mild pain 3-4 score: moderate pain 5-6 score: severe pain 7-8 score: very severe 9-10: worst pain possible Having lower scores means better outcome in terms of pain relief

    Time frame: 6 months

07

Study locations

1 site
  • Pakistan Institute of Medical Sciences
    Islamabad, Punjab Province 46604, Pakistan
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07203651
Lead sponsor
Pakistan Institute of Medical Sciences
Responsible party
Sidra Rauf (Postgraduate resident, Pakistan Institute of Medical Sciences) — Principal investigator
First posted
Oct 2, 2025
Start date
Jan 1, 2025
Primary completion
Jun 1, 2025
Completion
Jul 1, 2026 (estimated)
Last update
Oct 2, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion